Cardio Diagnostics Holdings, Inc. Logo

Cardio Diagnostics Holdings, Inc.

AI-powered epigenetic and genetic tests for early detection of heart disease risk.

CDIO | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
311 W. SUPERIOR STREET, 60645 CHICAGO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in artificial intelligence-driven cardiovascular medicine. The company develops and commercializes clinical tests that utilize a proprietary combination of epigenetics, genetics, and AI to enable the early detection and prevention of heart disease. Its core mission is to make cardiovascular care more accessible, personalized, and precise. By analyzing genetic and epigenetic markers, Cardio Diagnostics provides deep insights into an individual's risk of a heart attack, empowering healthcare providers with actionable intelligence for proactive and personalized patient management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardio Diagnostics Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardio Diagnostics Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cardio Diagnostics Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Advancing high-grade copper and precious metal projects from discovery to production.
Canada COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688

Talk to a Data Expert

Have a question? We'll get back to you promptly.